Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlotta Becherini

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
The Lancet. Oncology|February 1, 2024
International multidisciplinary consensus on the integration of radiotherapy with new systemic treatments for breast cancer: European Society for Radiotherapy and Oncology (ESTRO)-endorsed recommendationsIcro Meattini, Carlotta Becherini, Saverio Caini, et al.
La Radiologia Medica|October 22, 2024
Subclinical cardiac damage monitoring in breast cancer patients treated with an anthracycline-based chemotherapy receiving left-sided breast radiation therapy: subgroup analysis from a phase 3 trialLivia Marrazzo, Icro Meattini, Carlotta Becherini, et al.
Breast (Edinburgh, Scotland)|January 7, 2026
Concomitant radiation therapy and trastuzumab deruxtecan in metastatic breast cancer: feasibility, safety, and outcomes from a real-life multicentre international cohortLuca Visani, Ivica Ratosa, Rupert Bartsch, et al.
La Radiologia Medica|September 20, 2023
Stereotactic reirradiation with Cyberknife<sup>R</sup> for locally recurrent prostate cancer, long-term toxicity and clinical outcomes from a monocentric cohortGiulio Francolini, Maria Grazia Carnevale, Vanessa Di Cataldo, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 12, 2023
Safety profile of trastuzumab-emtansine (T-DM1) with concurrent radiation therapy: A systematic review and meta-analysisViola Salvestrini, Kyubo Kim, Saverio Caini, et al.
JAMA Oncology|August 26, 2021
Cardioprotective Strategy for Patients With Nonmetastatic Breast Cancer Who Are Receiving an Anthracycline-Based Chemotherapy: A Randomized Clinical TrialLorenzo Livi, Giuseppe Barletta, Francesca Martella, et al.
Cancers|February 11, 2023
Three Months' PSA and Toxicity from a Prospective Trial Investigating STereotactic sAlvage Radiotherapy for Macroscopic Prostate Bed Recurrence after Prostatectomy-STARR (NCT05455736)Giulio Francolini, Pietro Garlatti, Vanessa Di Cataldo, et al.
The Lancet. Oncology|January 1, 2022
European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancerIcro Meattini, Carlotta Becherini, Liesbeth Boersma, et al.
Clinical & Experimental Metastasis|April 3, 2023
Early biochemical outcomes following PSMA guided approach for bIoCHEmical relapse after prostatectomy-PSICHE trial (NCT05022914): preliminary resultsGiulio Francolini, Michele Ganovelli, Vanessa Di Cataldo, et al.
The Prostate|June 8, 2023
PSMA guided approach for bIoCHEmical relapse after prostatectomy- (PSICHE) trial (NCT05022914). Detection rate and treatment decision after 68Ga-PSMA PET/CT within a prospective studyGiulio Francolini, Marco Banini, Vanessa Di Cataldo, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
The Lancet. Oncology|February 1, 2024
International multidisciplinary consensus on the integration of radiotherapy with new systemic treatments for breast cancer: European Society for Radiotherapy and Oncology (ESTRO)-endorsed recommendationsIcro Meattini, Carlotta Becherini, Saverio Caini, et al.
La Radiologia Medica|October 22, 2024
Subclinical cardiac damage monitoring in breast cancer patients treated with an anthracycline-based chemotherapy receiving left-sided breast radiation therapy: subgroup analysis from a phase 3 trialLivia Marrazzo, Icro Meattini, Carlotta Becherini, et al.
Breast (Edinburgh, Scotland)|January 7, 2026
Concomitant radiation therapy and trastuzumab deruxtecan in metastatic breast cancer: feasibility, safety, and outcomes from a real-life multicentre international cohortLuca Visani, Ivica Ratosa, Rupert Bartsch, et al.
La Radiologia Medica|September 20, 2023
Stereotactic reirradiation with Cyberknife<sup>R</sup> for locally recurrent prostate cancer, long-term toxicity and clinical outcomes from a monocentric cohortGiulio Francolini, Maria Grazia Carnevale, Vanessa Di Cataldo, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 12, 2023
Safety profile of trastuzumab-emtansine (T-DM1) with concurrent radiation therapy: A systematic review and meta-analysisViola Salvestrini, Kyubo Kim, Saverio Caini, et al.
JAMA Oncology|August 26, 2021
Cardioprotective Strategy for Patients With Nonmetastatic Breast Cancer Who Are Receiving an Anthracycline-Based Chemotherapy: A Randomized Clinical TrialLorenzo Livi, Giuseppe Barletta, Francesca Martella, et al.
Cancers|February 11, 2023
Three Months' PSA and Toxicity from a Prospective Trial Investigating STereotactic sAlvage Radiotherapy for Macroscopic Prostate Bed Recurrence after Prostatectomy-STARR (NCT05455736)Giulio Francolini, Pietro Garlatti, Vanessa Di Cataldo, et al.
The Lancet. Oncology|January 1, 2022
European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancerIcro Meattini, Carlotta Becherini, Liesbeth Boersma, et al.
Clinical & Experimental Metastasis|April 3, 2023
Early biochemical outcomes following PSMA guided approach for bIoCHEmical relapse after prostatectomy-PSICHE trial (NCT05022914): preliminary resultsGiulio Francolini, Michele Ganovelli, Vanessa Di Cataldo, et al.
The Prostate|June 8, 2023
PSMA guided approach for bIoCHEmical relapse after prostatectomy- (PSICHE) trial (NCT05022914). Detection rate and treatment decision after 68Ga-PSMA PET/CT within a prospective studyGiulio Francolini, Marco Banini, Vanessa Di Cataldo, et al.
Pageof 8